NOVA Biomedical Corp.
Classification
Private
About
About
Nova Biomedical Corporation develops, manufactures, and sells blood testing analyzers. It provides hand held point-of-care analyzers, clinical analyzers, biotech analyzers, lactate meters for athletes, self testing monitors, and hospital based blood gas and critical care analyzers; and contract development and manufacturing services. The company serves healthcare companies, including diagnostic firms. It markets and sells its products through distributors in the United States and in more than 90 countries internationally. Nova Biomedical Corporation was incorporated in 1976 and is headquartered in Waltham, Massachusetts with manufacturing facilities in Taipei, Taiwan; Billerica and Waltham, MA. As of 2016 Nova is one of the 25 largest in vitro diagnostic companies in the world and the largest privately owned in vitro diagnostic company in the United States.
Financials
Revenue & Profit
Valuation
Ratios
People
Deals
M&A2024-03-15Completed
Investor Sponsors NorthBridge PE | Stake Tags 100% |
Deal Amount $120M | Is PE deal Yes |
Target Company Valuation $1.20 MM | Is deal PE backed Yes |
Techniques Acquisition of Assets, Taken Private | Total Acquired 100% |
Investor Sponsors
Deal Amount
$120M
Target Company Valuation
$1.20 MM
Techniques
Acquisition of Assets, Taken Private
Stake Tags
100%
Is PE deal
Yes
Is deal PE backed
Yes
Total Acquired
100%
Secondary Transaction2023-09-01Canceled
Investor Sponsors -- | Stake Tags Majority |
Deal Amount Undisclosed | Is PE deal No |
Target Company Valuation -- | Is deal PE backed Yes |
Techniques Secondary Sale, Management Buy-out (MBO) | Total Acquired 65% |
Investor Sponsors
--
Deal Amount
Undisclosed
Target Company Valuation
NaN
Techniques
Secondary Sale, Management Buy-out (MBO)
Stake Tags
Majority
Is PE deal
No
Is deal PE backed
Yes
Total Acquired
65%
Funding
Keywords
Keywords
Classified
Private